News from us and our partners

Tags

Topics

0 results

News
31 May, 2020
RGENIX Shows Clinical Activity of Novel Agent RGX-202 in Patients with KRAS Mutant Colorectal Cancer in Phase 1 Trial
News
28 May, 2020
RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy with Merck’s KEYTRUDA® for Certain Late-Stage Cancers
News
26 May, 2020
Biotalys awarded €1.6 million VLAIO research grant
News
25 May, 2020
Abivax Announces German Regulatory Approval of ABX464 Covid-19 Phase 2b/3 COVID-19 Clinical Trial
News
22 May, 2020
Comet Bio reports positive clinical results for Arrabina prebiotic
News
21 May, 2020
HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines
News
14 May, 2020
Abivax Receives ANSM and Ethics Committee Clearance to Test its Development Candidate ABX464 in 1,034 COVID-19 Patients in Randomized Phase 2B/3 Clinical Trial
News
14 May, 2020
ABX464 Inhibits Replication of SARS-CoV-2 (COVID-19) in Reconstituted Human Respiratory Epithelium Model
News
13 May, 2020
Genespire and SR-Tiget form gene therapy alliance
News
11 May, 2020
CorVent Medical, A Coridea Portfolio Company, Closes $4.5M Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator
News
6 May, 2020
PinCell Appoints Veteran Biotech and Biopharma Executives to Management Team and Board of Directors
News
6 May, 2020
Biotalys’ first biocontrol proves consistent, high efficacy in global fruit and vegetables field trial program
News
4 May, 2020
Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference
News
30 April, 2020
Pyrowave closes Series B led by Michelin and Sofinnova Partners
News
29 April, 2020
Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies
News
22 April, 2020
EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners

RGENIX Shows Clinical Activity of Novel Agent RGX-202 in Patients with KRAS Mutant Colorectal Cancer in Phase 1 Trial

RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy with Merck’s KEYTRUDA® for Certain Late-Stage Cancers

Biotalys awarded €1.6 million VLAIO research grant

Abivax Announces German Regulatory Approval of ABX464 Covid-19 Phase 2b/3 COVID-19 Clinical Trial

Comet Bio reports positive clinical results for Arrabina prebiotic

HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines

Abivax Receives ANSM and Ethics Committee Clearance to Test its Development Candidate ABX464 in 1,034 COVID-19 Patients in Randomized Phase 2B/3 Clinical Trial

ABX464 Inhibits Replication of SARS-CoV-2 (COVID-19) in Reconstituted Human Respiratory Epithelium Model

Genespire and SR-Tiget form gene therapy alliance

CorVent Medical, A Coridea Portfolio Company, Closes $4.5M Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator

PinCell Appoints Veteran Biotech and Biopharma Executives to Management Team and Board of Directors

Biotalys’ first biocontrol proves consistent, high efficacy in global fruit and vegetables field trial program

Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference

Pyrowave closes Series B led by Michelin and Sofinnova Partners

Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies

EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners